Skip to content

{ Tag Archives } Adults

Are Continuing Headaches A Health Warning?

Do you often discover yourself havingdull or even criticalintolerable headaches thatobstructs your absorption andprevents you from doing any work? Constant headaches are not uncommon. It is not secret that adults and children suffer from various types of headaches throughout their life. However, before going in for medication, it is essential that we understand the causes and study the symptoms in order to be able to diagnose the [...]

Bookmark and Share Also tagged , , , , , , , , , , , , , , , , , , , ,

Creating Beauty Out of Bargain Mineral Makeup

New Treatment For Psoriasis
Make up have been there for ages. These have been utilized by both adults for various purposes. Although these are more known to be used for vanity, some individuals who have serious skin disorders seek without the aid of makeup to conceal such dilemma. It’s not important whether you can simply afford [...]

Bookmark and Share Also tagged , , , , , , , , , , , , , , , , , , ,

Top Guide Of Acne And Treatment

{Generally}, teenagers or adolescents are vulnerable {to obtain} {pimple}. Some of them will have problems with {pimple} until they get adult, while others will not. The {pimple} can also become worse for ladies who cover their {pimple} by make-up. {Rather than} making it {much better}, the make-up {might} {really} worsen the condition. Stress and hormonal [...]

Bookmark and Share Also tagged , , , , , , , , , , , , , , , , , , ,

Basilea’s Toctino(R) Receives Marketing Authorization In Italy

Basilea Pharmaceutica Ltd. announces that Toctino® (alitretinoin), a new once-daily oral treatment for adults with severe chronic hand eczema (CHE) unresponsive to potent topical corticosteroids, has been approved by the Italian Drug Agency (Agenzia Italiana del Farmaco [AIFA])…

Bookmark and Share Also tagged , , , , , , , ,

What Is Heat Rash? What Is Prickly Heat? What Causes Heat Rash?

Heat rash, also known as prickly heat, sweat rash and miliaria, is an itchy, red skin rash that often causes a stinging or prickling sensation. It is common in infants but can affect adults too, especially during hot, humid weather. Heat rash develops when sweat ducts become blocked and perspiration is trapped under the [...]

Bookmark and Share Also tagged , , , , , , , , , , , , ,

Health Canada Approves Graceway Pharmaceuticals Product For Precancerous Skin Condition

Health Canada has approved Zyclara™ (imiquimod) Cream 3.75%, a topical prescription treatment for multiple actinic keratoses (AK) located on the face or balding scalp in adults. Actinic Keratosis is a common skin condition that can lead to squamous cell carcinoma, a form of non-melanoma skin cancer, if left untreated…

Bookmark and Share Also tagged , , , , , , , , , , , , , , ,

Basilea’s Toctino(R) Recommended For Approval In 15 Additional European Countries

Basilea Pharmaceutica Ltd. (SWISS: BSLN) announces that Toctino® (alitretinoin) was recommended for regulatory approval under the Repeat-use Procedure in 13 additional European Union (EU) Member States as well as in Norway and Iceland. Toctino® is a new once-daily oral treatment for adults with severe chronic hand eczema (CHE) unresponsive to potent topical corticosteroids…

Bookmark and Share Also tagged , , , , , , , , , , , ,

Charity Urges Government To Act Now And Put Restrictions On Sunbed Use, UK

Tomorrow Scotland takes steps to protect children from sunbeds by banning under 18s from using them and ensuring adults are fully informed of the risks, Cancer Research UK wants Westminster to bring the rest of the UK up to Scottish standards.

Bookmark and Share Also tagged , , , , , , ,

Basilea’s Toctino(R) Receives Marketing Authorization In Canada

Basilea Pharmaceutica Ltd. announces that Toctino® (alitretinoin), a new once-daily oral treatment for adults with severe chronic hand eczema (CHE) unresponsive to potent topical corticosteroids, has obtained regulatory approval from Health Canada. “We are delighted that Health Canada has approved the use of Toctino for patients with severe chronic hand eczema [...]

Bookmark and Share Also tagged , , , , , , , ,

Novexel Starts Phase II Clinical Trial With NXL103 In Adults With Acute Bacterial Skin And Skin Structure Infections (ABSSSI)

Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance, announces that its most advanced oral antibacterial NXL103 (flopristin/linopristin), has started a Phase II clinical trial in adults with acute bacterial skin and skin structure infections (ABSSSI).

Bookmark and Share Also tagged , , , , , , , , , , , ,